17 October 2017
News and Views
Links and Services
A study in November's issue of the Clinical Gastroenterology & Hepatology evaluates the efficacy of sofosbuvir and daclatasvir in fibrosing cholestatic Hepatitis C after liver transplantation.
Fibrosing cholestatic hepatitis is a life-threating disorder that develops in patients with recur
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors